Plasma Exchange

• 

  Subject Areas on Research

  • A case of severe thrombotic thrombocytopenic purpura with concomitant Legionella pneumonia: review of pathogenesis and treatment. 
  • A large university medical center delivery system for therapeutic apheresis services. 
  • A population-based analysis on the use of therapeutic plasma exchange and intravenous immunoglobulin in heparin-induced thrombocytopenia. 
  • A retrospective study of complications of therapeutic plasma exchange in myasthenia. 
  • ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy. 
  • Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States. 
  • Alternatives to albumin: starch replacement for plasma exchange. 
  • Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts. 
  • Apheresis. New opportunities. 
  • Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. 
  • Bleeding outcomes of inpatients receiving therapeutic plasma exchange: A propensity-matched analysis of the National Inpatient Sample. 
  • Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations. 
  • Central venous catheters are associated with thrombosis among adult inpatients undergoing therapeutic plasma exchange. 
  • Clinical aspects of MuSK antibody positive seronegative MG. 
  • Clinical outcome measures following plasma exchange for MG exacerbation. 
  • Clinical outcomes of cardiac surgery patients undergoing therapeutic plasma exchange for heparin-induced thrombocytopenia. 
  • Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. 
  • Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis. 
  • Effects of therapeutic plasma exchange on anticoagulants in patients receiving therapeutic anticoagulation: a systematic review. 
  • Evaluation of serum immunoglobulins by protein electrophoresis and rate nephelometry before and after therapeutic plasma exchange. 
  • Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. 
  • Hemostatic effects of therapeutic plasma exchange: A concise review. 
  • How I treat catastrophic thrombotic syndromes. 
  • How I treat thrombocytopenia in pregnancy. 
  • Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner. 
  • Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura. 
  • Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study. 
  • International consensus guidance for management of myasthenia gravis: Executive summary. 
  • Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy. 
  • Management of Gardner-Diamond syndrome with therapeutic plasma exchange. 
  • Novel therapeutic approaches for thrombotic thrombocytopenic purpura. 
  • Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state. 
  • Plasma exchange in pancreatitis due to hypertriglyceridemia. 
  • Plasma exchange in rapidly progressive renal failure due to multiple myeloma. A retrospective case series. 
  • Randomised trial of plasma exchange in mild systemic lupus erythematosus. 
  • Relapse of thrombotic thrombocytopenic purpura: is it a continuum of disease? 
  • Role of C1q complement fixing antibody assay in therapeutic plasma exchange management of pediatric cardiac antibody mediated rejection. 
  • Severe primary refractory thrombotic thrombocytopenic purpura (TTP) in the post plasma exchange (PEX) and rituximab era. 
  • Techniques and applications of perioperative therapeutic plasma exchange. 
  • The top clinical trial opportunities in therapeutic apheresis and neurology. 
  • The treatment of nephrogenic systemic fibrosis with therapeutic plasma exchange. 
  • Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: A systematic review. 
  • Therapeutic plasma exchange for management of heparin-induced thrombocytopenia: Results of an international practice survey. 
  • Therapeutic plasma exchange in the management of immune checkpoint inhibitor-associated immune-related adverse effects: A review. 
  • Thrombophilia and thrombosis in thrombotic thrombocytopenic purpura. 
  • Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infection. 
  • Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research. 
  • Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). 
  • Treatment modalities in Guillain-Barré syndrome. 
  • Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure. 
  • Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. 
  • United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange. 
  • Use of therapeutic plasma exchange in heparin-induced thrombocytopenia: A population-based study.